Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1000 participants.
Also called NCT05774691
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 1,000 participants
- Sponsor
- Registry
-
NCT05774691
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT05774691. Randomized; triple masking; primary purpose prevention. Start 2023-11-01 (actual); primary completion 2026-01-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Routine Versus Selective Protamine Administration to Reduce Bleeding Complications After Transcatheter Aortic Valve Implantation (POPular ACE TAVI)
- Condition
- Aortic Valve Stenosis
- Intervention (Drug)
- Protamine sulfate
- Intervention (Drug)
- Protamine sulfate
- Lead sponsor
- St. Antonius Hospital
- Collaborator
- St. Antonius Research Fund
Record details
- Record id
cardio:ct-nct05774691- Content hash
f344fe6194b00626a688c1d60ba470a17e3ca7bf0809475f6404f08f90071291